HomeCompareSTSA vs PEP

STSA vs PEP: Dividend Comparison 2026

STSA yields 136.36% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STSA wins by $15.42M in total portfolio value
10 years
STSA
STSA
● Live price
136.36%
Share price
$1.10
Annual div
$1.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.56M
Annual income
$6,371,447.45
Full STSA calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — STSA vs PEP

📍 STSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTSAPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STSA + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STSA pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSA
Annual income on $10K today (after 15% tax)
$11,590.91/yr
After 10yr DRIP, annual income (after tax)
$5,415,730.33/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, STSA beats the other by $5,363,136.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSA + PEP for your $10,000?

STSA: 50%PEP: 50%
100% PEP50/50100% STSA
Portfolio after 10yr
$7.85M
Annual income
$3,216,661.56/yr
Blended yield
40.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

STSA
Analyst Ratings
4
Buy
9
Hold
Consensus: Hold
Altman Z
-7.4
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSA buys
0
PEP buys
0
No recent congressional trades found for STSA or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTSAPEP
Forward yield136.36%3.63%
Annual dividend / share$1.50$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$15.56M$141.9K
Annual income after 10y$6,371,447.45$61,875.67
Total dividends collected$14.30M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold

Year-by-year: STSA vs PEP ($10,000, DRIP)

YearSTSA PortfolioSTSA Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$24,336$13,636.36$10,849$509.42+$13.5KSTSA
2$57,055$31,014.91$11,969$750.47+$45.1KSTSA
3$129,004$67,955.30$13,500$1,124.14+$115.5KSTSA
4$281,633$143,598.62$15,680$1,721.66+$266.0KSTSA
5$594,333$292,985.93$18,929$2,715.34+$575.4KSTSA
6$1,213,779$577,842.64$24,023$4,450.80+$1.19MSTSA
7$2,401,642$1,102,898.48$32,510$7,669.92+$2.37MSTSA
8$4,609,241$2,039,484.49$47,709$14,093.60+$4.56MSTSA
9$8,590,007$3,658,118.87$77,415$28,083.48+$8.51MSTSA
10$15,562,755$6,371,447.45$141,922$61,875.67+$15.42MSTSA

STSA vs PEP: Complete Analysis 2026

STSAStock

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Full STSA Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this STSA vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSA vs SCHDSTSA vs JEPISTSA vs OSTSA vs KOSTSA vs MAINSTSA vs MOSTSA vs PMSTSA vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.